{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:19:38Z","timestamp":1766578778113},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,14]]},"DOI":"10.7759\/cureus.29143","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:11:09Z","timestamp":1663139469000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Vasopressin Alone or in Combination With Catecholamines in the Treatment of Septic Shock: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Naishal","family":"Mandal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nang I","family":"Kham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabia","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaili S","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivana","family":"Ramphall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarnima","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishakh","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Ekladios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiya","family":"Mulayamkuzhiyil  Saju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathish","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr FB","year":"2014","unstructured":"Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014, 5:4-11. 10.4161\/viru.27372","journal-title":"Virulence"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002722","article-title":"Time course of septic shock in immunocompromised and nonimmunocompromised patients","volume":"45","author":"Jamme M","year":"2017","unstructured":"Jamme M, Daviaud F, Charpentier J, et al.. Time course of septic shock in immunocompromised and nonimmunocompromised patients. Crit Care Med. 2017, 45:2031-9. 10.1097\/CCM.0000000000002722","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002283","article-title":"Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial","volume":"45","author":"Bergamin FS","year":"2017","unstructured":"Bergamin FS, Almeida JP, Landoni G, et al.. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med. 2017, 45:766-73. 10.1097\/CCM.0000000000002283","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger RP","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41:580-637. 10.1097\/CCM.0b013e31827e83af","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser MW","year":"2009","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009, 24:293-316. 10.1177\/0885066609340519","journal-title":"J Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4249-z","article-title":"Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum","volume":"42","author":"Andreis DT","year":"2016","unstructured":"Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016, 42:1387-97. 10.1007\/s00134-016-4249-z","journal-title":"Intensive Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer D","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010, 362:779-89. 10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer JC","year":"2018","unstructured":"Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest. 2018, 154:416-26. 10.1016\/j.chest.2017.12.021","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell JA","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al.. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008, 358:877-87. 10.1056\/NEJMoa067373","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the Vanish randomized clinical trial","volume":"316","author":"Gordon AC","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, et al.. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the Vanish randomized clinical trial. JAMA. 2016, 316:509-18. 10.1001\/jama.2016.10485","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry DW","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, et al.. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997, 95:1122-5. 10.1161\/01.cir.95.5.1122","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Serpa Neto A","year":"2012","unstructured":"Serpa Neto A, Nassar AP, Cardoso SO, et al.. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012, 16:R154. 10.1186\/cc11469","journal-title":"Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials","volume":"10","author":"Belletti A","year":"2015","unstructured":"Belletti A, Musu M, Silvetti S, et al.. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS One. 2015, 10:e0142605. 10.1371\/journal.pone.0142605","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre WF","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, et al.. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018, 319:1889-900. 10.1001\/jama.2018.4528","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2018.04.006","article-title":"Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"32","author":"D\u00fcnser MW","year":"2018","unstructured":"D\u00fcnser MW, Bouvet O, Knotzer H, Arulkumaran N, Hajjar LA, Ulmer H, Hasibeder WR. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018, 32:2225-32. 10.1053\/j.jvca.2018.04.006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell JA","year":"2009","unstructured":"Russell JA, Walley KR, Gordon AC, et al.. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009, 37:811-8. 10.1097\/CCM.0b013e3181961ace","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: vasopressin in the management of septic shock","volume":"15","author":"Russell JA","year":"2011","unstructured":"Russell JA. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care. 2011, 15:226. 10.1186\/cc8224","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera G","year":"2000","unstructured":"Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept. 2000, 96:23-9. 10.1016\/s0167-0115(00)00196-8","journal-title":"Regul Pept"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue A","year":"2004","unstructured":"Tanoue A, Ito S, Honda K, et al.. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest. 2004, 113:302-9. 10.1172\/JCI19656","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004023","article-title":"Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the Vancs II randomized clinical trial","volume":"47","author":"Hajjar LA","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A, et al.. Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the Vancs II randomized clinical trial. Crit Care Med. 2019, 47:1743-50. 10.1097\/CCM.0000000000004023","journal-title":"Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2017(12)06","article-title":"Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline","volume":"72","author":"Nascente AP","year":"2017","unstructured":"Nascente AP, Freitas FG, Bakker J, et al.. Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline. Clinics (Sao Paulo). 2017, 72:750-7. 10.6061\/clinics\/2017(12)06","journal-title":"Clinics (Sao Paulo)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001149","article-title":"Practice patterns and outcomes associated with choice of initial vasopressor therapy for septic shock","volume":"43","author":"Fawzy A","year":"2015","unstructured":"Fawzy A, Evans SR, Walkey AJ. Practice patterns and outcomes associated with choice of initial vasopressor therapy for septic shock. Crit Care Med. 2015, 43:2141-6. 10.1097\/CCM.0000000000001149","journal-title":"Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201604-259OC","article-title":"Epidemiology of vasopressin use for adults with septic shock","volume":"13","author":"Vail EA","year":"2016","unstructured":"Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H. Epidemiology of vasopressin use for adults with septic shock. Ann Am Thorac Soc. 2016, 13:1760-7. 10.1513\/AnnalsATS.201604-259OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2346","article-title":"Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock","volume":"40","author":"Yerke JR","year":"2020","unstructured":"Yerke JR, Sacha GL, Scheraga RG, et al.. Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock. Pharmacotherapy. 2020, 40:33-9. 10.1002\/phar.2346","journal-title":"Pharmacotherapy"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223602","article-title":"Symmetrical peripheral gangrene of bilateral feet and unilateral hand after administration of vasopressors during septic shock","volume":"2018","author":"Ruffin N","year":"2018","unstructured":"Ruffin N, Vasa CV, Breakstone S, Axman W. Symmetrical peripheral gangrene of bilateral feet and unilateral hand after administration of vasopressors during septic shock. BMJ Case Rep. 2018, 2018:bcr223602. 10.1136\/bcr-2017-223602","journal-title":"BMJ Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20180060","article-title":"Use of vasopressin in the treatment of refractory septic shock","volume":"30","author":"Kny KT","year":"2018","unstructured":"Kny KT, Ferreira MA, Pizzol TD. Use of vasopressin in the treatment of refractory septic shock. Rev Bras Ter Intensiva. 2018, 30:423-8. 10.5935\/0103-507X.20180060","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183073","article-title":"Septic shock and the use of norepinephrine in an intermediate care unit: mortality and adverse events","volume":"12","author":"Hallengren M","year":"2017","unstructured":"Hallengren M, \u00c5strand P, Eksborg S, Barle H, Frostell C. Septic shock and the use of norepinephrine in an intermediate care unit: mortality and adverse events. PLoS One. 2017, 12:e0183073. 10.1371\/journal.pone.0183073","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-020-00965-4","article-title":"Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis","volume":"20","author":"Huang L","year":"2020","unstructured":"Huang L, Zhang S, Chang W, Xia F, Liu S, Yang Y, Qiu H. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis. BMC Anesthesiol. 2020, 20:58. 10.1186\/s12871-020-00965-4","journal-title":"BMC Anesthesiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00500-0","article-title":"Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials","volume":"8","author":"Zhong L","year":"2020","unstructured":"Zhong L, Ji XW, Wang HL, Zhao GM, Zhou Q, Xie B. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials. J Intensive Care. 2020, 8:83. 10.1186\/s40560-020-00500-0","journal-title":"J Intensive Care"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2015.07.016","article-title":"Effects of terlipressin on patients with sepsis via improving tissue blood flow","volume":"200","author":"Xiao X","year":"2016","unstructured":"Xiao X, Zhang J, Wang Y, et al.. Effects of terlipressin on patients with sepsis via improving tissue blood flow. J Surg Res. 2016, 200:274-82. 10.1016\/j.jss.2015.07.016","journal-title":"J Surg Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu ZM","year":"2018","unstructured":"Liu ZM, Chen J, Kou Q, et al.. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018, 44:1816-25. 10.1007\/s00134-018-5267-9","journal-title":"Intensive Care Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"Morelli A","year":"2008","unstructured":"Morelli A, Ertmer C, Lange M, et al.. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008, 100:494-503. 10.1093\/bja\/aen017","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106648-efficacy-and-safety-of-vasopressin-alone-or-in-combination-with-catecholamines-in-the-treatment-of-septic-shock-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:52Z","timestamp":1707508072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106648-efficacy-and-safety-of-vasopressin-alone-or-in-combination-with-catecholamines-in-the-treatment-of-septic-shock-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.29143","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}